Open AccessA Study of Safety and Efficacy of Nivolumab and Bendamustine (NB) in Patients With Relapsed/Refractory Hodgkin Lymphoma After Nivolumab Monotherapy Failure
Author(s) -
Lepik Kirill V.,
Mikhailova Natalia B.,
Kondakova Elena V.,
Zalyalov Yuri R.,
Fedorova Liudmila V.,
Tsvetkova Luibov A.,
Kotselyabina Polina V.,
Borzenkova Evgeniya S.,
Babenko Elena V.,
Popova Marina O.,
Darskaya Elena I.,
Baykov Vadim V.,
Moiseev Ivan S.,
Afanasyev Boris V.
Publication year - 2020
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/hs9.0000000000000401
Subject(s) - nivolumab , bendamustine , medicine , refractory (planetary science) , oncology , lymphoma , rituximab , cancer , materials science , immunotherapy , metallurgy
Supplemental Digital Content is available in the text